A

Aspect Biosystems

Bioprints allogeneic tissue therapeutics

Director Clinical Operations

Clinical Research OperationsConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • A bachelor's degree in Life Sciences, Nursing, or a related scientific discipline is required.
  • Eight years of related clinical-trial experience with progressively increasing responsibility, including four years in a leadership position; less experienced, driven individuals may be considered.
  • Experience developing cell or gene therapy products, including rare diseases.
  • Experience leading early clinical development programs, including launching first-in-human trials.
  • Experience working in early-stage, fast-paced biotechnology environments with lean internal teams.
  • Experience with surgical routes of administration for investigational products.
  • Understanding and application of ICH Guidelines, the Code of Federal Regulations, and Good Clinical Practice.
  • Working knowledge of logistics unique to cell therapies.
  • Experience operationalizing and managing multicenter, multinational Phase I–III trials.
  • Experience issuing requests for proposals, selecting contract research organizations and specialty vendors, and managing complex program budgets.
  • Understanding of global regulatory frameworks governing advanced therapy medicinal products and cellular-therapy regenerative medicines.
  • Adaptability when faced with change, ambiguity, and competing priorities.
  • Ability to solve difficult technical problems and assess whether proposed solutions are realistic.
  • A master's degree would be highly beneficial.

Responsibilities

  • Lead the operational strategy, startup, execution, and closeout of global Phase I–III cell therapy clinical trials, and support additional responsibilities assigned by leadership.
  • Translate clinical development plans into operational milestones, study budgets, resource plans, and risk-mitigation strategies.
  • Direct cross-functional study execution teams, including Clinical Development, Regulatory, Quality, Chemistry, Manufacturing, and Controls, and promote cross-department knowledge sharing.
  • Partner with Chemistry, Manufacturing, and Controls and Supply Chain to establish cell therapy protocols for chain of identity, chain of custody, cryogenic transport, and site handling.
  • Author, review, and standardize trial documents, including protocols, informed consents, Investigator's Brochures, study manuals, and Clinical Operations standard operating procedures.
  • Drive international site identification, feasibility, qualification, and activation, targeting specialized academic medical centers, endocrinology units, and cell therapy treatment centers.
  • Manage clinical portions of regional regulatory submissions to the Food and Drug Administration, European Medicines Agency, Health Canada, and Medicines and Healthcare products Regulatory Agency, and manage ethics approvals with Regulatory Affairs and local contract research organization partners.
  • Develop country-specific patient recruitment and retention strategies for target populations.
  • Build and maintain key opinion leader and site investigator partnerships.
  • Lead vendor selection, including requests for proposals, bid defenses, and negotiations, and oversee performance governance, scope tracking, and quality management for contract research organizations, central laboratories, and specialty providers.
  • Create, negotiate, review, and approve clinical-trial, vendor, site, and department budgets, invoices, change orders, and accruals with Finance.
  • Build and scale the Clinical department by establishing foundational standard operating procedures, setting up electronic trial master file structures, and hiring, training, and managing team members.
  • Maintain inspection readiness for trial activities, sites, electronic trial master file systems, and vendor records, and ensure compliance with ICH-GCP guidelines and global cell and gene therapy regulations.

Desired Qualifications

  • A master's degree.

About the Company

Aspect Biosystems

Bioprints allogeneic tissue therapeutics

Aspect Biosystems develops bioprinted tissue therapeutics for regenerative medicine. Its work centers on a platform that combines proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design to create allogeneic tissue therapeutics for clinical use. The company works through strategic collaborations with leading pharmaceutical and biotechnology firms, funded by partnerships and investors. The product approach uses bioprinting to assemble tissue constructs layer by layer from cells and biomaterials, guided by computational design, producing off-the-shelf (allogeneic) tissue therapies. What sets the company apart is its integrated platform, a focus on allogeneic, scalable tissue products, and a collaboration-driven business model with strong industry partnerships, backed by a solid funding base. Its goal is to advance regenerative medicine by delivering a targeted pipeline of bioprinted tissue therapeutics through collaborations and continued investment.

Company size
51-200
Company stage
Grant
Total funding
$352.7M
Headquarters
Vancouver, Canada
Founded
2013

Recently Posted Jobs

Explore more opportunities at Aspect Biosystems

See more jobs